- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Ajooni Biotech's board approved its financial results for the quarter ended June 30. Revenue was ₹63.49 Cr, with a net profit of ₹0.43 Cr. EPS stood at ₹0.01.